TEXAS CAPITAL BANCSHARES INC/TX (TCBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 200K 400K 600K FY09: 568K FY10: 238K FY11: 149K FY09 FY10 FY11

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Annual

0 150M 300M 450M FY09: 18.8M FY10: 37.2M FY11: 76M FY12: 120.7M FY13: 121.1M FY14: 136.4M FY15: 144.9M FY16: 155.1M FY17: 196.1M FY18: 293.4M FY19: 312M FY20: 66.3M FY21: 253.9M FY22: 332.5M FY23: 189.1M FY24: 77.5M FY25: 330.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-900M 0 900M 1.8B 2.7B FY09: -140.9M FY10: -403.9M FY11: 75.9M FY12: 89.3M FY13: 191.4M FY14: 157.7M FY15: 68.9M FY16: -726.3M FY17: 132.2M FY18: -679.7M FY19: -240.2M FY20: 2.6B FY21: 657.3M FY22: 148M FY23: 373.7M FY24: 480.1M FY25: 360.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-900M 0 900M 1.8B 2.7B FY09: -145.5M FY10: -407.8M FY11: 72.6M FY12: 85.7M FY13: 187.3M FY14: 142M FY15: 63.9M FY16: -728.5M FY17: 119.9M FY18: -687.4M FY19: -256.8M FY20: 2.6B FY21: 653.2M FY22: 136.7M FY23: 357.4M FY24: 415.2M FY25: 347.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 20M 40M 60M FY09: 34.4M FY10: 37.3M FY11: 38.3M FY12: 40.2M FY13: 41.8M FY14: 44M FY15: 46.4M FY16: 46.8M FY17: 50.3M FY18: 50.3M FY19: 50.4M FY20: 50.6M FY21: 51.1M FY22: 51M FY23: 48.6M FY24: 47M FY25: 46.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.00 6.00 9.00 Q4 '10: 1.00 Q1 '11: 1.10 Q2 '11: 1.31 Q3 '11: 1.62 Q4 '11: 1.97 Q1 '12: 2.36 Q2 '12: 2.69 Q3 '12: 2.93 Q4 '12: 3.02 Q1 '13: 3.12 Q2 '13: 2.88 Q3 '13: 2.82 Q4 '13: 2.73 Q1 '14: 2.53 Q2 '14: 2.72 Q3 '14: 2.76 Q4 '14: 2.87 Q1 '15: 2.97 Q2 '15: 3.02 Q3 '15: 2.99 Q4 '15: 2.91 Q1 '16: 2.70 Q2 '16: 2.72 Q3 '16: 2.84 Q4 '16: 3.10 Q1 '17: 3.41 Q2 '17: 3.60 Q3 '17: 3.85 Q4 '17: 3.73 Q1 '18: 4.31 Q2 '18: 4.72 Q3 '18: 5.25 Q4 '18: 5.79 Q1 '19: 6.01 Q2 '19: 6.13 Q3 '19: 6.18 Q4 '19: 6.03 Q1 '20: 4.05 Q2 '20: 1.82 Q3 '20: 1.20 Q4 '20: 1.11 Q1 '21: 2.82 Q2 '21: 4.86 Q3 '21: 4.54 Q4 '21: 4.59 Q1 '22: 3.95 Q2 '22: 3.23 Q3 '22: 3.21 Q4 '22: 6.25 Q1 '23: 6.26 Q2 '23: 7.00 Q3 '23: 7.44 Q4 '23: 3.55 Q1 '24: 3.31 Q2 '24: 2.78 Q3 '24: 0.19 Q4 '24: 1.27 Q1 '25: 1.73 Q2 '25: 2.51 Q3 '25: 6.10 Q4 '25: 6.80 Q1 '26: 7.44 Q2 '26: 7.69 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.